Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.

@article{Sanders2020PharmacologicTF,
  title={Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.},
  author={James M Sanders and M. Monogue and T. Jodlowski and James B Cutrell},
  journal={JAMA},
  year={2020}
}
  • James M Sanders, M. Monogue, +1 author James B Cutrell
  • Published 2020
  • Medicine
  • JAMA
  • Importance The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented challenge to identify effective drugs for prevention and treatment. Given the rapid pace of scientific discovery and clinical data generated by the large number of people rapidly infected by SARS-CoV-2, clinicians need accurate evidence regarding effective medical treatments for this infection. Observations No proven… CONTINUE READING

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    The COVID-19 pandemic is of grave concern due its impact on human health and on the economy. Propolis, a natural resin produced by bees from plant materials, has anti-inflammatory… Expand
    ConditionsCovid19
    InterventionDrug, Other

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 93 REFERENCES
    Broad-spectrum coronavirus antiviral drug discovery
    44